Form 144 PACIFIC BIOSCIENCES OF Filed by: HENRY CHRISTIAN O
Pacific Biosciences of California, Inc. (PACB)
Last pacific biosciences of california, inc. earnings: 2/6 04:02 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.pacificbiosciences.com
Company Research
Source: SEC EDGAR
Impact Snapshot
Event Time:
PACB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PACB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PACB alerts
High impacting Pacific Biosciences of California, Inc. news events
Weekly update
A roundup of the hottest topics
PACB
News
- PacBio to Report First Quarter 2026 Financial Results on May 7, 2026GlobeNewswire
- PacBio and Covaris Announce Joint Workflow Enabling HiFi Long-Read Sequencing of FFPE Tumor SamplesGlobeNewswire
- Pacific Biosciences of California (PACB) had its price target lowered by Barclays PLC from $1.50 to $1.00. They now have an "underweight" rating on the stock.MarketBeat
- Pacific Biosciences (PACB) Garnering Attention Amid Involvement in Trillion Gene Atlas Program [Yahoo! Finance]Yahoo! Finance
- Assembling Over 1,000 Human Genomes Affordably: New Method Powers Medicine's Future [Yahoo! Finance]Yahoo! Finance
PACB
Earnings
- 2/12/26 - Beat
PACB
Sec Filings
- 4/10/26 - Form 4
- 4/3/26 - Form 4
- 4/1/26 - Form 144
- PACB's page on the SEC website